Table 3 Analysis of endpoints
Endpoints | Experimental group (N = 40) | Control group (N = 18) | Statistics | P |
|---|---|---|---|---|
Whether grade 3/4 neutropenia occurs | χ2 = 26.64 | < 0.001 | ||
Yes | 4 (10.00%) | 14 (77.78%) | ||
No | 36 (90.00%) | 4 (22.22%) | ||
The duration of grade 3–4 neutropenia a | Z = 0.16 | 0.871 | ||
n | 4 | 14 | ||
Median (Q1,Q3) | 3.5 (3.0,4.5) | 3.5 (3.0,9.0) | ||
Whether grade 4 neutropenia occurs | χ2 = 4.50 | 0.034 | ||
Yes | 3 (7.50%) | 6 (33.33%) | ||
No | 37 (92.50%) | 12 (66.67%) | ||
Whether FN occurs | 0.026 | |||
Yes | 0 | 3 (16.67%) | ||
No | 40 (100.00%) | 15 (83.33%) | ||
Whether chemotherapy is delayed | χ2 = 12.35 | < 0.001 | ||
Yes | 5 (12.50%) | 11 (61.11%) | ||
No | 35 (87.50%) | 7 (38.89%) | ||
Prolonged time of chemotherapy b | Z = 1.94 | 0.052 | ||
n | 5 | 11 | ||
Median (Q1,Q3) | 4.0 (3.0,6.0) | 9.0 (7.0,11.0) | ||
Time to complete radiotherapy c | t = 0.89 | 0.375 | ||
n | 40 | 18 | ||
Mean ± SD | 43.55 ± 6.91 | 45.22 ± 5.80 | ||
Whether bone pain occurs | χ2 = 1.99 | 0.159 | ||
Yes | 1 (2.50%) | 3 (16.67%) | ||
No | 39 (97.50%) | 15 (83.33%) |